CD25 appears non essential for human peripheral T(reg) maintenance in vivo

Marie-Ghislaine de Goër de Herve1, Emmanuel Gonzales, Houria Hendel-Chavez

  • 1Unité d'Immunologie Biologique, CHU Bicêtre, Le Kremlin-Bicêtre, France.

Plos One
|August 7, 2010
PubMed
Summary

Basiliximab, an anti-CD25 antibody, did not deplete regulatory T cells (Tregs) in pediatric liver transplant patients. However, altered Treg function was suggested by increased food allergies post-transplant.